Searchable abstracts of presentations at key conferences in endocrinology

ea0086p281 | Thyroid | SFEBES2022

The potential interaction between medical treatment and radioiodine treatment success: a systematic review

Zannat Riazul , Lee Jonathan , Muzaffar Jameel , Read Martin L. , Brookes Katie , Sharma Neil , Boelaert Kristien , McCabe Christopher J. , Nieto Hannah T.

Introduction: Radioactive iodine (RAI) therapy is a critical component in the post-surgical management of thyroid cancer patients, as well as being a central therapeutic option in the treatment of hyperthyroidism. Previous work suggests that antithyroid drugs hinder the efficacy of RAI therapy in patients. However, the effects of other background medications on RAI treatment efficacy have not been evaluated. Therefore, we performed a systematic review and metanalysis investiga...

ea0081ep553 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

‘The results of the Echo-cardiographic investigations in patients with diabetic foot syndrome and chronic heart failure’

Kamalov Telman , Khaydarov Muzaffar

The purpose of the study is to study the echo-cardiographic disorders in patients with diabetic foot syndrome (DFS) and chronic heart failure (CHF)Material and methods: The study was conducted in 62 patients with SDS treated in the department of surgical diseases and civil defense of the Andijan State Medical Institute in 2019 - 2021. The following groups of patients were formed: 1 gr - patients with DM 2Type and the neuroichemic form of DFS and HSN-31 p...

ea0081ep554 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

‘The Hemodynamic indicators in patients with diabetic foot syndrome and chronic heart failure’

Kamalov Telman , Khaydarov Muzaffar

The purpose of the study is to study the Hemodynamic indicators in patients with diabetic foot syndrome (DFS) and chronic heart failure (CHF) Material and methods: The study was conducted in 62 patients with SDS treated in the department of surgical diseases and civil defense of the Andijan State Medical Institute in 2019 - 2021. The following groups of patients were formed: 1 gr - patients with DM 2 Type and the neuroichemic form of DFS and HSN-31 patie...

ea0090ep545 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The activation value of the renin-angiotensin-aldosterone system in the pathogenesis of late complications of DM 2

Mirzaev K.K. , Khaydarov Muzaffar

Aim: To study the indicators of RAAS in patients with DM 2 with chronic heart failure (CHF) and diabetic foot syndrome (DFS).Material and methods: We observed 75 patients with DM 2, CHF and DFS. Patients were distributed into 3 groups: 1 gr – patients with 2 t and neuroichemic form of DFS and CHF – 22 patients, 2 groups – patients with DM 2 and neuroichemic form of DFS without CHF – 28 patients, 3 groups – patients with CHF witho...

ea0090ep576 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The state of central hemodynamics in patients with diabetic foot syndrome is associated with chronic heart failure

Khaydarov Muzaffar , Mirzaev K.K.

Aim: Study results of ultrasound dopplerography of the heart in patients with neuroischemic form of diabetic foot syndrome associated with chronic heart failure.Material and methods: We examined 64 patients with DM 2 and DFS in the neuroischemic form on the basis of the Department of Surgery of the AndesMI. The patients were divided into 4 groups:1 gr – patients with neuroischemic form of DFS and CHF– 15 patients, gr. 2 – patients with neu...

ea0059p039 | Bone and calcium | SFEBES2018

Management of hypoparathyroidism against European guidelines: Experience of a large teaching hospital

Jamal Jameel , Scholes Amelia , Sagar Rebecca , Abbas Afroze

Background: Hypoparathyroidism is a rare endocrine disorder characterised by low serum calcium with inappropriately low parathyroid hormone (PTH) levels. Calcium and vitamin D analogues have traditionally been the mainstay of treatment. However, these treatments may cause complications and may not fully address the well-being of this patient group. This study evaluates the current management of hypoparathyroidism in a large UK teaching hospital compared against current Europea...

ea0013p29 | Clinical practice/governance and case reports | SFEBES2007

Hyperkalemia in a district general hospital

Rajeev Surya P , Nair Satheesh B , Mahmood Muhammed Muzaffar , Geen John , Baglioni Piero

Objectives: To assess the aetiology and management of hyperkalemia amongst inpatients in a district general hospital.Methods: Individuals with hyperkalemia (defined as potassium>6.5 mmol/L) were identified from a biochemistry lab database. Review of case records in a six month period to assess the aetiology and management. Patients on renal replacement therapy and those<18 years were excluded.Results: 45 patients were ident...

ea0041ep113 | Bone &amp; Osteoporosis | ECE2016

Is carbonhydrate intake a risk factor for postmenopausal spinal osteoporosis?

Kurtulus Duygu , Humeyra Bicer Ayse , Selcen Bicer Hatice , Ilhan Muzaffer

Introduction: Osteoporosis is a disease that is characterized by bone mass loss and deterioration in bone micro-architecture. One of the most important risk factors is dietary habits. The effects of the amount of calcium intake via eating, and low calcium consumption on the development of osteoporosis is still an active research area. The intestinal absorption of calcium and its renal excretion are still not understood very well. Even though the effects of carbohydrates on cal...

ea0035p667 | Female reproduction | ECE2014

Increased prolactin levels cause increased MPV in women with PCOS

Yilmaz Ozgur , Calan Mehmet , Temur Muzaffer , Kume Tuncay , Yesil Pinar

Introduction: It is well known association between cardiovascular disease and PCOS. Approximately 17–43% of women with PCOS have hyperprolactinemia. Increased levels of prolactin often associated with an increased risk for thromboembolic events, but underline pathophisiological mechanism still unknown. The strong association between hyperprolactinemia and platelet aggregation is well known. Platelets play a key role in the development of atherothrombosis, a major contribu...

ea0026p701 | Diabetes complications | ECE2011

Receptor activator of nuclear factor kappa β ligand and osteoprotegerin levels in the patients with diabetic nephropathy

Kuzuguden Cigdem , Guldiken Sibel , Ustundag Sedat , Ozgen Zeren , Demir Muzaffer

Aim: The aim of this study was to investigate the relationship between the clinical and laboratory findings of metabolic bone disease regarding the levels of osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (RANKL) in the patients with diabetic nephropathy.Material and method: This study includes 61 type 2 diabetic patients and age-, sex-matched 20 healthy subjects. Diabetic patients were divided into three groups accordi...